Atlas Trials

Trial for Safety and Immunogenicity of a Chikungunya Vaccine, VRC-CHKVLP059-00-VP, in Healthy Adults

Clinical trial NCT02562482 · COMPLETED

Trial details

NCT number
NCT02562482
Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Chikungunya Virus Infection
Start date
2015-11-18
Primary completion
2018-03-06
Enrollment
400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.